PurePEG, LLC is a leading supplier of highly pure, monodispersed polyethylene glycol (PEG) products. With 12 years of experience to date, we are committed to providing the highest quality PEG reagents to fit any application.
WELCOME TO PurePEG
PEGs have earned their place in the biomedical field due to their water solubility, non-toxicity, and non-immunogenicity properties. They are widely used in research for bioconjugation, assays, and bioorthogonal labeling purposes. To date, there are 12 PEGylated drugs approved by the FDA for treatment of a number of chronic diseases, with more approvals pending. PurePEG developed the first acid functionalized PEG used in an FDA approved antibody-drug conjugate (ADC drug) used to treat breast cancer. PEG’s impact on biological therapies cannot be understated. Despite a wider market of suppliers and manufacturers of PEG, PurePEG still stands at the forefront with our unparalleled quality of PEG and our ever-expanding PEG research and development
CustomSynthesis
High-quality custom synthesis and contract research
Certificate of Analysis (CoA)
Mass spectrometry data
Analytical Test Methods
Low cost research
Quality Responsibilities
Control of documents
PurePEG specializes in supplying PEG reagents with discrete molecular weights, offering PEG reagents with up to min.99% purity
While most PEG products are a mixture of different molecular weights, PurePEG supplies monodisperse, sin gle molecular weight molecules. Through our innovative PurePEG TM technology, we have the ability to manufa cture high quality monodisperse PEGs with precise molecular weights in high purities. We also offer custom man ufacturing services for various related PEG compounds that aren’t found on our site’s catalog. Drop us an email at [email protected] to inquire further about our capabilities.
NEWS & EVENTS
Welcome to the new PurePEG
We have redesigned our website to better suit client needs! Please take a look around and browse our new and expanded catalog.
For all new and existing PurePEG clients, I invite you to save 15% off your next order by completing a short survey in regards to our new website. Please follow the link below and complete the survey...
LEARN MOREPEGylated dendrimers: a new way to deliver drugs
Our researchers, in collaboration with the biotechnology company Starpharma Holdings Ltd (ASX:SPL), have developed a new drug delivery method that could benefit thousands of patients worldwide with particular types of cancer, HIV and lymphatic conditions.
The Melbourne-based research team has shown...
LEARN MORE10th International Peptide Symposium and 55th Japanese Peptide Symposium
10th International Peptide Symposium and 55th Japanese Peptide Symposium
ROHM Theatre Kyoto
13 Okazaki Saishōjichō
Sakyō-ku, K...
256th ACS National Meeting & Exposition
256th ACS National Meeting & Exposition
Boston, Massachsetts
415 Summer St. – Boston
Date/Time
Aug 19, 2018 ̵...